Abstract:Phenanthriplatin drug (PhenPt) is encapsulated with a reduction sensitive polymer to form PhenPt NP. Such PhenPt NP act as STING agonists to convert "cold tumor" into "hot tumor", which greatly enhances the efficacy of chemo‐immunotherapy. Furthermore, the combination of PhenPt NP with checkpoint blockade therapy (a‐PD‐L1) elicits long‐term immune response on both primary and distant tumors by activating cGAS‐STING pathway. STING agonists have made great progress in tumor immunotherapy. However, the inherent instability and low bioavailability have limited their wide applications. Herein, a reduction sensitive polymer with pair‐wised carboxyl groups that further encapsulate a cationic phenanthriplatin drug (PhenPt) as STING agonists into nanoparticles (PhenPt NPs) via electrostatic interactions is designed. PhenPt NP can release PhenPt in cancer cells, which then induce DNA damage, activate the STING signaling pathway, stimulate innate and adaptive immune responses, and improve the chemo‐immunotherapy efficacy. In vitro, for the first time it is found that PhenPt NP can activate cGAS‐STING pathway. Further genome‐wide RNA‐sequencing reveals that DNA replication, mismatch repair, homologous recombination, and other gene repair‐related pathways are involved. In vivo, PhenPt NP are found to completely inhibit the tumor growth, thereby shifting the tumor microenvironment from immunosuppressive to immunostimulatory phenotype, and boosting antitumor immune responses for long‐term immunity. In addition, PhenPt NP combined with checkpoint blockade therapy (a‐PD‐L1) can elicit long‐term immune response on both primary and distant tumors by activating the cGAS‐STING pathway. Overall, this nano‐delivery system with cationic chemotherapeutic drugs can greatly enhance DNA damage and activate immunity, hence providing a promising strategy for enhanced chemo‐immunotherapy.

Platinum Prodrug Nanoparticles with COX‐2 Inhibition Amplifies Pyroptosis for Enhanced Chemotherapy and Immune Activation of Pancreatic Cancer

Endowing Pt(IV) with Perfluorocarbon Chains and Human Serum Albumin Encapsulation for Highly Effective Antitumor Chemoimmunotherapy.

Nanoparticle Delivery of a Triple-Action Pt(iv) Prodrug to Overcome Cisplatin Resistance Via Synergistic Effect

Dual-Coordinated atomically dispersed Pt nanozymes evoke efficient pyroptosis for cancer immunotherapy

Engineering Prodrug Nanomicelles As Pyroptosis Inducer for Codelivery of PI3K/mTOR and CDK Inhibitors to Enhance Antitumor Immunity.

PtNi Nano Trilobal-Based Nanostructure with Magnetocaloric Oscillation and Catalytic Effects for Pyroptosis-Triggered Tumor Immunotherapy

Self-assembled Metal-Phenolic Network Nanoparticles for Delivery of a Cisplatin Prodrug for Synergistic Chemo-Immunotherapy

In-situ oxidative polymerization of platinum(IV) prodrugs in pore-confined spaces of CaCO3 nanoparticles for cancer chemoimmunotherapy

Self-Assembled Metal-Phenolic Network Nanoparticles Delivery of Cisplatin Prodrug for Synergistic Chemo-Immunotherapy

Biomimetic Nanoparticle Synchronizing Pyroptosis Induction and Mitophagy Inhibition for Anti-Tumor Therapy.

Engineered Nanogels Simultaneously Implement HDAC Inhibition and Chemotherapy to Boost Antitumor Immunity Via Pyroptosis

Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy

Encapsulation of Platinum Prodrugs into PC7A Polymeric Nanoparticles Combined with Immune Checkpoint Inhibitors for Therapeutically Enhanced Multimodal Chemotherapy and Immunotherapy by Activation of the STING Pathway

Endogenous/exogenous stimulies inspired polyprodrug nano-inducer switches pyroptosis path for promoting antitumor immunity

A Dual Stimuli‐responsive Nanoplatform Loaded PtIV‐triptolide Prodrug for Achieving Synergistic Therapy Toward Breast Cancer

Diselenide‐Based Dual‐Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy

Plasmon‐Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway

Reduction Sensitive Polymers Delivering Cationic Platinum Drugs as STING Agonists for Enhanced Chemo‐Immunotherapy

Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy

Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy

Development of Facile and Versatile Platinum Drug Delivering Silicasome Nanocarriers for Efficient Pancreatic Cancer Chemo-Immunotherapy